The luminal short-chain fatty acid butyrate modulates NF-κB activity in a human colonic epithelial cell line
Top Cited Papers
- 1 April 2000
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 118 (4), 724-734
- https://doi.org/10.1016/s0016-5085(00)70142-9
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitisGastroenterology, 1999
- Intestinal NF-κB is activated, mainly as p50 homodimers, by platelet-activating factorBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998
- Effects of steroid treatment on activation of nuclear factor κB in patients with inflammatory bowel diseaseBritish Journal of Pharmacology, 1998
- NFkappaB prevents apoptosis and liver dysfunction during liver regeneration.Journal of Clinical Investigation, 1998
- Butyrate Stimulates Cyclin D and p21 and Inhibits Cyclin-Dependent Kinase 2 Expression in HT-29 Colonic Epithelial CellsBiochemical and Biophysical Research Communications, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994
- Stimulation of lamina propria lymphocytes by intestinal epithelial cells: evidence for recognition of nonclassical restriction elements.The Journal of Experimental Medicine, 1994
- The IκB proteins: members of a multifunctional familyTrends in Genetics, 1993
- Treatment of Diversion Colitis with Short-Chain-Fatty Acid IrrigationNew England Journal of Medicine, 1989